Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StatVax: Atorvastatin Effect on Pneumovax 23 Response
NCT02097589Phase 1Completed
- Sponsor
- University of Florida
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of atorvastatin in hypercholesterolemia, sponsored by University of Florida. Primary endpoint: Pneumococcal antigen specific antibody production at 49 days. Started Jun 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02097589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097589.